Jamie Reynoso, Clover Health CEO, sells $17,931 in stock

Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp. (NASDAQ:CLOV), sold 4,066 shares of the company’s Class A Common Stock on October 19, 2026. The transactions totaled $17,931. The shares were sold at prices ranging from $4.32 to $4.54, with a weighted average price of $4.41 per share. The stock currently trades at $4.80, up nearly 50% over the past year, though InvestingPro data suggests the shares may be overvalued relative to its Fair Value estimate. According to InvestingPro Tips, analysts predict the company will be profitable this year, with earnings expected in 14 days. The platform offers 7 additional exclusive tips for CLOV, along with comprehensive Pro Research Reports available for over 1,400 US stocks.

Following this sale, Mr. Reynoso directly holds 2,770,351 shares of Class A Common Stock. The sale was executed under a Rule 10b5-1 trading plan, which Mr. Reynoso adopted on March 12, 2026.

In other recent news, Clover Health exceeded Wall Street’s expectations for the second quarter of 2026. The company reported adjusted earnings of 5 cents per share, surpassing the anticipated 4 cents per share. Revenue for the quarter reached $743.2 million, beating the forecasted $728.27 million. This represents a 56% increase in revenue compared to the same quarter the previous year. Additionally, Clover Health has raised its full-year outlook, indicating confidence in its ongoing performance. These developments have been well-received by investors.